Shoulder Replacement Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F

Resurfacing Hemiarthroplasty is the fastest growing sector, North America is the largest market

The Global Shoulder Replacement Market is projected to expand significantly, from USD 2.08 Billion in 2025 to USD 3.26 Billion by 2031, demonstrating a 7.78% Compound Annual Growth Rate. Shoulder arthroplasty, the surgical removal and prosthetic replacement of damaged bone and cartilage in the glenohumeral joint, aims to restore mobility and alleviate pain.

This growth is primarily fueled by a rapidly aging global population and the increasing incidence of osteoarthritis requiring surgical intervention after conservative treatments fail. Additionally, a rise in sports-related injuries and trauma consistently contributes to higher procedural volumes, establishing a fundamental market demand. However, the sector faces challenges from post-operative complications such as implant loosening and infection, which can necessitate costly revision surgeries and deter patient adoption. These clinical risks are further complicated by patient comorbidities; for instance, the American Academy of Orthopaedic Surgeons' 2025 Shoulder & Elbow Registry Annual Report indicated that 51.2% of shoulder arthroplasty patients were obese, a crucial factor surgeons must manage for successful long-term implant outcomes.

Market Drivers

The Global Shoulder Replacement Market is significantly influenced by the integration of robotic-assisted surgical systems, which enhance implant placement accuracy and reduce the incidence of revision surgeries. Surgeons are increasingly adopting these advanced platforms for highly precise pre-operative planning, ensuring optimal positioning of the glenoid component, which is vital for long-term implant durability. This technological advancement serves as a substantial commercial catalyst, boosting the sales of compatible high-tech implant systems. Stryker Corporation, in its October 2025 Q3 earnings call, reported robust double-digit organic sales growth in its Upper Extremities business, directly attributing this performance to sustained market demand for its advanced surgical solutions.

Furthermore, the market's expansion is driven by the growing prevalence of rotator cuff tears and sports-related injuries, which increasingly necessitate surgical intervention, particularly reverse total shoulder arthroplasty. As active demographics age, the incidence of complex cuff tear arthropathy has surged, establishing replacement surgery as a primary treatment rather than a last resort. This trend is corroborated by large-scale registry data; the American Academy of Orthopaedic Surgeons' October 2025 Shoulder & Elbow Registry Annual Report identified rotator cuff tears as the second leading primary diagnosis among 27,461 analyzed shoulder arthroplasty procedures. Concurrently, the National Joint Registry's September 2025 22nd Annual Report underscored procedural stability in developed regions, documenting 9,809 shoulder replacement procedures during its latest reporting period.

Market Challenges

Post-operative complications, specifically implant loosening and periprosthetic infections, pose a significant impediment to the growth of the global shoulder replacement market. These clinical failures not only compromise patient recovery and long-term outcomes but also necessitate technically complex and considerably more expensive revision arthroplasty. The substantial financial and physical burden associated with such adverse events creates a psychological disincentive for potential candidates, often leading them to delay or entirely forgo surgery despite experiencing debilitating joint pain. Consequently, the market's expansion is hampered as the inherent risks of device failure reduce the adoption rates of otherwise effective prosthetic solutions.

The magnitude of this issue is amplified by the sheer volume of shoulder replacement procedures performed; even a low complication rate translates into a considerable absolute number of revisions, thereby straining healthcare resources. For instance, the National Joint Registry's 2025 22nd Annual Report revealed that 9,809 shoulder procedures were submitted for analysis in the preceding calendar year. As such high procedural volumes continue to climb, the cumulative demand for managing long-term implant survivorship acts as a critical constraint. This economic pressure directly hinders market growth by reallocating crucial funds and surgical capacity away from new growth opportunities.

Market Trends

The shoulder arthroplasty landscape is undergoing a significant transformation due to the rapid adoption of procedures performed in outpatient and ambulatory surgery centers (ASCs), a shift propelled by advancements in pain management techniques and favorable payer incentives. This change represents a strategic redirection as healthcare providers increasingly favor cost-effective, high-efficiency settings for joint replacement. The operational and financial benefits of this model are evident in the performance of leading facility operators aggressively expanding their orthopedic service lines; for example, Surgery Partners reported a 16% growth in total joint surgeries within its ASC facilities during the third quarter of 2025, according to its November 2025 Q3 earnings call, highlighting the accelerated migration of procedures away from traditional hospital environments.

Concurrently, the emergence and proliferation of 3D-printed patient-specific implants and instrumentation are revolutionizing anatomical reconstruction by overcoming the limitations of conventional off-the-shelf prosthetics. Manufacturers are leveraging additive manufacturing to produce highly porous titanium structures that closely mimic natural bone, thereby improving biologic fixation and ensuring superior long-term implant stability. This technological evolution is a significant driver of commercial growth, as surgeons increasingly seek personalized solutions for complex glenoid deformities. Enovis Corporation’s February 2025 report on its Fourth Quarter and Full Year 2024 Results indicated a 59% reported sales growth in its Reconstructive segment, a surge directly linked to the strategic acquisition and successful integration of LimaCorporate’s advanced 3D-printed implant portfolio.

Key Market Players

• Arthrex Inc
• Zimmer Biomet Holdings Inc
• Integra LifeSciences Corporation
• Johnson & Johnson Services, Inc.
• Smith & Nephew PLC
• Wright Medical Group NV
• Stryker Corporation
• DJO Global Inc
• Acumed Inc
• Exactech Inc

Report Scope

In this report, the Global Shoulder Replacement Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Shoulder Replacement Market, by Type:

• Anatomical Shoulder Prosthesis
• Reverse Shoulder Prosthesis

Shoulder Replacement Market, by Procedure:

• Resurfacing Hemiarthroplasty
• Reverse Total Shoulder Replacement
• Stemmed Hemiarthroplasty
• Total Shoulder Replacement

Shoulder Replacement Market, by End-User:

• Hospitals
• Orthopedic Centers
• Others

Shoulder Replacement Market, by Region:

• North America
• Europe
• Asia Pacific
• South America
• Middle East & Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Shoulder Replacement Market.

Available Customizations:

With the given market data, the publisher offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.